New Long-term Data 'Clearly Favor' Combination Ipilimumab/Nivolumab in Melanoma

[@deechr1602]

Thank you!

[@brandonpartee8277]

Thanks for this post. My question is why does he say you do not want liver METs when treated with immunotherapy? Is it purely based on the percentage?

[@roshand6580]

Please comment on Amelanotic Melanoma for 49yrs old male : Colorectal colostomy surgery done.

[@madhavikotian6624]

What about the drug efficiency of this adjuvant therapy on metastatic Submucosal spindle cell Amelanotic Melanoma patients with wildtype of B-RAF Wild type. Any study or comparitive analysis on these cases?

[@losbedsurfers5623]

hi